Risk-prediction tools in prostate cancer: the challenge of tailoring
Asian J Androl
.
2016 Nov-Dec;18(6):952.
doi: 10.4103/1008-682X.179526.
Authors
Alessandro Morlacco
1
,
Jiahua Pan
2
,
R Jeffrey Karnes
1
Affiliations
1
Department of Urology, Mayo Clinic, Rochester, MN, USA.
2
Department of Urology, Renji Hospital, Shanghai, China.
PMID:
27212124
PMCID:
PMC5109897
DOI:
10.4103/1008-682X.179526
No abstract available
Publication types
Comment
MeSH terms
Humans
Male
Prostate-Specific Antigen*
Prostatic Neoplasms*
Risk
Risk Assessment
Substances
Prostate-Specific Antigen